QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jinnah, H. A. Articles by Friedmann, T. Search for Related Content PubMed PubMed Citation Articles by Jinnah, H. A. Articles by Friedmann, T.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 14, 1164-1175, Copyright © 1994 by Society for Neuroscience

ARTICLE

Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease

HA Jinnah, BE Wojcik, M Hunt, N Narang, KY Lee, M Goldstein, JK Wamsley, PJ Langlais and T Friedmann
Department of Neurosciences, University of California San Diego School of Medicine, La Jolla 92093.

We have examined several aspects of neurotransmitter function in the brains of mice carrying a deletion mutation in the gene encoding the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). During the first 6 weeks of postnatal development, dopamine levels in whole-brain extracts from the mutant mice (HPRT-) failed to increase at rates comparable to normal animals, resulting in 40% lower dopamine levels throughout adulthood. Regional analysis in adult animals showed the caudoputamen to be the most severely affected region, with dopamine deficits of 48-64%. Dopamine levels in other regions were normal or less severely affected. The decrease in dopamine was accompanied by a decrease in tyrosine hydroxylase (TH) activity, the rate-limiting step in dopamine synthesis. Kinetic analysis of TH extracted from the caudoputamen of normal and HPRT- mice demonstrated a 45% decrease in Vmax with an increased affinity for the tetrahydropterin cofactor in the mutants. Labeling of midbrain dopamine neurons using TH immunohistochemistry revealed no obvious deficits in the number of midbrain dopamine neurons, but quantitative autoradiographic studies revealed significant reductions in the binding of 3H-N-[1-(2-benzo(beta)thiophenyl)cyclohexyl]piperidine (3H-BTCP) to dopamine uptake sites in the forebrain of the mutants. In contrast to these abnormalities of the dopamine systems in the mutant mice, other neurotransmitter systems appeared relatively unaffected. Norepinephrine, 5-HT, tryptophan hydroxylase, and glutamic acid decarboxylase were present at normal levels in the brains of the mutants. ChAT activity was slightly lower than normal in the caudoputamen of the mutant animals, but was normal in all other brain regions examined. These results indicate that HPRT deficiency is associated with a relatively specific deficit in basal ganglia dopamine systems that emerges during the first 2 months of postnatal development.

This article has been cited by other articles:

				C. Yokoyama and H. Okamura Self-Injurious Behavior and Dopaminergic Neuron System in Neonatal 6-Hydroxydopamine-Lesioned Rat: 1. Dopaminergic Neurons and Receptors J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1016 - 1030. [Abstract] [Full Text]

				F. M. Filloux Neuropathophysiology of Movement Disorders in Cerebral Palsy J Child Neurol, November 1, 1996; 11(1_suppl): S5 - S12. [Abstract] [PDF]

				M. Ernst, A. J. Zametkin, J. A. Matochik, D. Pascualvaca, P. H. Jons, K. Hardy, J. G. Hankerson, D. J. Doudet, and R. M. Cohen Presynaptic Dopaminergic Deficits in Lesch-Nyhan Disease N. Engl. J. Med., June 13, 1996; 334(24): 1568 - 1572. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help